Echinacea for Immune Function
Echinacea has not been shown to reliably "boost" immune function in healthy people. Lab and surrogate-marker effects exist, but the strongest human trial found no benefit, so the overall evidence is weak and mixed.
Why this grade7-layer evidence engine
This claim earns a weak (C) grade because the evidence pulls in two directions and rests on small, heterogeneous studies. Echinacea shows real immunomodulatory activity in cells and animals, and surrogate-marker reviews report shifts in cytokines such as IL-6, IL-8, TNF and IL-10 (PMID 34341776) and broadly positive immune signals across older controlled trials (PMID 23195946). But both reviews were rated low quality with generally high risk of bias, and the authors themselves said the data are insufficient for clear recommendations.
The decisive point against an immune-boosting claim is the best-controlled human study: a double-blind, placebo-controlled crossover RCT in healthy young men (PMID 12218779) found that oral echinacea produced no enhancement of phagocytic activity or TNF-alpha/IL-1beta. In other words, the test-tube effects did not translate to a measurable immune lift after swallowing it. On hard clinical endpoints, meta-analyses show only modest benefit: reduced recurrent respiratory infections (RR 0.65; PMID 25784510) and lower URTI incidence (RR 0.78) but no effect on illness duration (PMID 31126553).
Regulators and clinics reinforce the cautious read. The US FDA has warned that echinacea products marketed as treatments are "unapproved new drugs," while the UK (MHRA/NHS) registers it only as a traditional herbal product "based on traditional use only," and the WHO monographs cover quality control and traditional use rather than endorsing efficacy. Mayo Clinic notes any cold benefit "may be too minor to notice." Because "immune function" is a vague endpoint backed mainly by small surrogate-marker studies, with the headline oral-immune-stimulation claim unsupported in healthy humans, the evidence stays weak rather than strong.
Scoring transparency
All scores computed by a 7-layer evidence engine — fully auditable▸View the full decision path (audit trail)
- compute_raw_score — 加權公式: L2×0.30 + L3×0.25 + L5×0.25 + L11×0.10 + L1×0.10 = 0.448
- tier_from_score — 依分數區間映射至 tier letter
- apply_hec_rules — 高階證據未達主導 (1 positive vs 1 negative)，由 raw_score 決定
- tier_strict_requirement_check — Tier 條件達標，未降階
- detect_disputes — 偵測到 0 個 hard + 0 個 soft dispute
- decide_status — 依 tier + dispute 結果決定 status